A more transplant-specific approach can include the change of tacrolimus by an alternative immunosuppressant (cyclosporine or mTOR inhibitor), the decrease or cessation of corticosteroid therapy [69], and caution in the prescribing of diuretics since they are independently connected with post-transplant diabetes [182,183]. This evidence concerns the gene MTOR and diabetes mellitus.